Coherus Oncology, Inc. (CHRS)
NASDAQ·Healthcare·Biotechnology
$1.50
+3.82%
Mkt Cap $179.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
Implied Upside
+302.7%
Consensus $6.02 vs current $1.50
NASDAQ·Healthcare·Biotechnology
$1.50
+3.82%
Mkt Cap $179.94M
No recent rating data.
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
+302.7%
Consensus $6.02 vs current $1.50